Madrigal Pharmaceuticals, Inc. (MDGL)
Market: NASD |
Currency: USD
Address: Four Tower Bridge
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.
📈 Madrigal Pharmaceuticals, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$420.67
-
Upside/Downside from Analyst Target:
48.79%
-
Broker Call:
27
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
10-25%
-
Net Income Growth Range (1Y):
10-25%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2016 |
- |
$0.028571 |
- |
2016-07-25 |
- |
Stock split |
|
Total Amount for 2016: $0.028571 |
📅 Earnings & EPS History for Madrigal Pharmaceuticals, Inc.
| Date | Reported EPS |
|---|
| 2026-04-29 (estimated upcoming) | - |
| 2026-02-24 (estimated upcoming) | - |
| 2025-10-29 (estimated upcoming) | - |
| 2025-10-28 (estimated upcoming) | - |
| 2025-08-05 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-05-05 | - |
| 2025-05-04 | - |
| 2025-05-01 | -3.32 |
| 2025-02-26 | -2.71 |
| 2025-02-25 | - |
| 2025-01-13 | - |
| 2024-10-31 | -4.92 |
| 2024-08-07 | -7.1 |
| 2024-08-06 | -7.1 |
| 2024-05-07 | -7.38 |
| 2024-05-06 | -7.38 |
| 2024-02-28 | -5.68 |
| 2024-02-27 | -5.68 |
| 2023-11-06 | -5.34 |
| 2023-11-05 | -5.34 |
| 2023-08-08 | -4.69 |
| 2023-08-07 | -4.69 |
| 2023-05-09 | -4.23 |
| 2023-05-08 | -4.23 |
| 2023-02-23 | -4.98 |
| 2023-02-22 | -4.98 |
| 2022-11-03 | -4.75 |
| 2022-11-02 | -4.75 |
| 2022-08-04 | -4.14 |
| 2022-08-03 | -4.14 |
| 2022-05-09 | -3.36 |
| 2022-05-08 | -3.36 |
| 2022-02-24 | -3.78 |
| 2022-02-23 | -3.78 |
| 2021-11-04 | -3.79 |
| 2021-11-03 | -3.79 |
| 2021-08-05 | -3.72 |
| 2021-08-04 | -3.72 |
| 2021-05-06 | -3.32 |
| 2021-05-05 | -3.32 |
| 2021-02-25 | -3.82 |
| 2021-02-24 | -3.82 |
| 2020-11-05 | -3.75 |
| 2020-11-04 | -3.75 |
| 2020-08-06 | -3.18 |
| 2020-08-05 | -3.18 |
| 2020-05-07 | -2.34 |
| 2020-05-06 | -2.34 |
| 2020-02-25 | -1.8 |
| 2019-11-05 | -1.39 |
| 2019-08-06 | -1.28 |
| 2019-05-07 | -0.98 |
| 2019-02-26 | -0.75 |
| 2018-11-05 | -0.56 |
| 2018-08-06 | -0.45 |
| 2018-05-07 | -0.45 |
| 2018-03-12 | -0.67 |
| 2017-11-08 | -0.68 |
| 2017-08-09 | -0.69 |
| 2017-05-10 | -0.5 |
| 2017-03-30 | -0.67 |
| 2016-11-13 | -1.59 |
| 2016-07-19 | -0.7 |
| 2016-05-09 | -1.75 |
| 2016-03-14 | -2.8 |
| 2015-11-04 | -4.55 |
| 2015-08-05 | -5.25 |
| 2015-05-06 | -6.65 |
| 2015-03-11 | -6.65 |
| 2014-11-05 | -6.65 |
| 2014-08-05 | -8.4 |
| 2014-05-07 | -9.8 |
| 2014-03-10 | -10.85 |
| 2013-11-03 | -11.55 |
| 2013-07-31 | -11.55 |
| 2013-04-29 | -10.5 |
| 2013-03-13 | -10.15 |
| 2012-11-05 | -8.75 |
| 2012-08-01 | -8.75 |
| 2012-05-02 | -9.45 |
| 2012-02-21 | -7.7 |
| 2011-11-02 | -10.5 |
| 2011-08-03 | -10.5 |
| 2011-05-04 | -9.45 |
| 2010-11-03 | -8.75 |
| 2010-08-08 | -7.7 |
| 2010-05-03 | -8.4 |
| 2010-03-10 | -7.35 |
| 2009-11-03 | 121.8 |
| 2009-08-03 | -8.75 |
| 2009-05-06 | -24.15 |
| 2009-03-25 | -26.95 |
| 2008-11-12 | -27.3 |
| 2008-08-06 | -23.45 |
| 2008-05-13 | -18.2 |
| 2008-03-19 | -16.1 |
| 2007-11-12 | -15.75 |
| 2007-08-05 | -17.5 |
| 2007-05-06 | -19.95 |
📰 Related News & Research
No related articles found for "madrigal pharmaceuticals".
